Stay updated on CB-839 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the CB-839 in Solid Tumors Clinical Trial page.

Latest updates to the CB-839 in Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page; no content or functionality changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedLocations section was updated with a new Locations header and added state entries (California, Florida, Georgia, Maryland, Massachusetts, New York, Pennsylvania, Tennessee, Texas), while state-specific entries were removed, and the page revision updated to v3.3.3.SummaryDifference0.9%

- Check54 days agoChange DetectedRevision: v3.3.2 was added to the page and Revision: v3.2.0 was removed.SummaryDifference0.0%

- Check61 days agoChange DetectedRemoved a site-wide funding-status notice about government funding. The study details page content remains unchanged.SummaryDifference0.3%

- Check75 days agoChange DetectedScreenshots show only minor UI/label tweaks with no change to core sections such as the Brief Summary, Eligibility Criteria, Study Plan, or Locations, and the study title, conditions, and primary outcomes remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check104 days agoChange DetectedUpdate includes a critical operating-status notice and a new software version (v3.2.0), indicating updated deployment; removal of the prior version tag (v3.1.0) accompanies the upgrade.SummaryDifference4%

Stay in the know with updates to CB-839 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CB-839 in Solid Tumors Clinical Trial page.